Piramal Enterprises strengthens after its division enters into strategic partnership with Ci-Co Healthcare

22 Nov 2013 Evaluate

Piramal Enterprises is currently trading at Rs. 543.00, up by 7.65 points or 1.43 % from its previous closing of Rs. 535.35 on the BSE.

The scrip opened at Rs. 540.00 and has touched a high and low of Rs. 547.65 and Rs. 537.15 respectively. So far 1121 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 648.30 on 02-Sep-2013 and a 52 week low of Rs. 475.00 on 22-Nov-2012.

Last one week high and low of the scrip stood at Rs. 562.00 and Rs. 533.50 respectively. The current market cap of the company is Rs. 9370.18 crore.

The promoters holding in the company stood at 52.97% while Institutions and Non-Institutions held 30.63% and 16.40% respectively

Ci-Co Healthcare and Piramal Imaging SA, a division of Piramal Enterprises have entered into a strategic partnership and exclusive licensing agreement whereby Ci-Co Healthcare will obtain market authorization from the Korean Health Authorities and commercialize the PET amyloid imaging agent, florbetaben F18, in South Korea. Ci-Co Healthcare has assigned the manufacturing and supply of florbetaben F18 to DuChemBio, a market leading radiopharmacy network in Korea.

Piramal Enterprises is one of India’s largest diversified companies, with a presence in pharmaceutical, financial services and information management sectors.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 997.60
Shriram Finance 955.35
Aditya Birla Capital 346.80
Chola Invest & Fin. 1698.35
Tata Capital 337.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×